Optimization of important early ADME(T) parameters of NADPH oxidase-4 inhibitor molecules

Through their reactive oxygen species (ROS) producing function, NADPH oxidase (NOX) enzymes have been linked to several oxidative stress related diseases. In our recently published paper [1] we have already shown the NOX4 inhibitory effect of diverse, molecule sub-libraries and their biological importance. We also presented our work connected to potential anti-tumour molecules and the relationship between their biological activity and physico-chemical properties [2]. As an extension of these studies further physico-chemical and biological investigation has been carried out on a molecule group included NOX4 inhibitory chromanone compounds. Here we describe the optimization of early ADME(T) parameters determining lipophilicity, phospholipophilicity and permeability linked to structure-activity relationship. We prove that optimal lipo- and phospholipophilicty can be also determined in case of NOX4 inhibitors and a comparison will be made between the chemically similar isochromanone and chromanone molecular libraries. It will be also shown how to predict the effect of different substituents on permeability, lipo- and phospholipophilicity and also the biological differences between anti-tumour molecules and NOX4 inhibitors according to their penetration ability.

Medienart:

E-Artikel

Erscheinungsjahr:

2012

Erschienen:

2012

Enthalten in:

Zur Gesamtaufnahme - volume:8

Enthalten in:

Medicinal chemistry (Shariqah (United Arab Emirates)) - 8(2012), 2 vom: 28. März, Seite 174-81

Sprache:

Englisch

Beteiligte Personen:

Borbély, Gábor [VerfasserIn]
Huszár, Ménika [VerfasserIn]
Varga, Attila [VerfasserIn]
Futosi, Krisztina [VerfasserIn]
Mócsai, Attila [VerfasserIn]
Orfi, László [VerfasserIn]
Idei, Miklós [VerfasserIn]
Mandl, József [VerfasserIn]
Kéri, György [VerfasserIn]
Vántus, Tibor [VerfasserIn]

Themen:

EC 1.6.3.-
Enzyme Inhibitors
Journal Article
NADPH Oxidase 4
NADPH Oxidases
NOX4 protein, human
Research Support, Non-U.S. Gov't

Anmerkungen:

Date Completed 05.11.2012

Date Revised 21.10.2021

published: Print

Citation Status MEDLINE

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM215896491